Ming-Hsin Yang
Papers
2
Total Citations
7
H-Index
2
About
Ming-Hsin Yang is a urologic oncologist whose research focuses on improving surgical outcomes and biomarker prediction in genitourinary cancers, particularly upper tract urothelial carcinoma (UTUC) and prostate cancer. In a pivotal 2021 study, Yang compared robot-assisted nephroureterectomy (RANU) with hand-assisted retroperitoneoscopic nephroureterectomy (HANU) for UTUC, examining perioperative circulating tumor cells (CTCs) as a marker of tumor dissemination. This work, cited 5 times, provided early evidence that robotic approaches may offer oncologic advantages by reducing CTC release during surgery. More recently, Yang introduced a novel concept—body mass weighted PSA levels—as a refined tool to predict locally advanced prostate cancer following prostatectomy. This 2024 study, with 2 citations, addresses the well-known inverse relationship between obesity and PSA concentration, proposing a simple adjustment to improve risk stratification in obese patients. By bridging surgical technique with biomarker innovation, Yang’s contributions advance personalized surgical decision-making and postoperative surveillance. Their work is particularly relevant for researchers exploring minimally invasive oncology and the interplay between patient physiology and cancer biomarkers.
Research Focus
Key Achievements
Top Papers
- 1
- 2